期刊文献+

Platelet-rich plasma application in diabetic ulcers:A review

下载PDF
导出
摘要 There are 422 million diabetic people in the world.25%of these individuals are diagnosed with diabetic foot ulcer(DFU).20%of patients with DFU will suffer amputation of the lower limbs.Following amputation procedures,the mortality rate of patients is over 70%in 5 years.Diabetes has no cure and,therefore,treatment aims to prevent and treat its complications.Autologous platelet-rich plasma(PRP)has been shown to be a therapeutic tool for many types of disorders,including the treatment of DFU.This manuscript aims to carry out a review to provide more knowledge about the efficacy and safety of autologous PRP for wound closure in patients with DFU.The majority of studies included in this review state that PRP promotes improvement of DFU lesions by accelerating tissue healing processes.However,many studies have a small sample size and thus require larger sample range in order to improve robustness of data in the literature.
出处 《World Journal of Dermatology》 2022年第1期1-9,共9页 世界皮肤病学杂志
  • 相关文献

参考文献2

二级参考文献179

  • 1International Diabetes Federation. IDF Diabetes Atlas. 6th ed.Brussels, Belgium: International Diabetes Federation, 2013.
  • 2Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, FreemanR, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabeticneuropathies: a statement by the American Diabetes Association.Diabetes Care 2005; 28: 956-962 [PMID: 15793206 DOI:10.2337/diacare.28.4.956].
  • 3Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and managementof diabetic painful distal symmetrical polyneuropathy. Diabetes Care2013; 36: 2456-2465 [PMID: 23970715 DOI: 10.2337/dc12-1964].
  • 4Boulton AJ, Kirsner RS, Vileikyte L. Clinical practice. Neuropathicdiabetic foot ulcers. N Engl J Med 2004; 351: 48-55 [PMID:15229307 DOI: 10.1056/NEJMcp032966].
  • 5Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH. Vascular risk factors anddiabetic neuropathy. N Engl J Med 2005; 352: 341-350 [PMID:15673800 DOI: 10.1056/NEJMoa032782].
  • 6Low PA, Dotson RM. Symptomatic treatment of painfulneuropathy. JAMA 1998; 280: 1863-1864 [PMID: 9846782 DOI:10.1001/jama.280.21.1863].
  • 7Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathyin adults with NIDDM in the U.S. population. Diabetes Care 1993;16: 1446-1452 [PMID: 8299433 DOI: 10.2337/diacare.16.11.1446].
  • 8Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgrad MedJ 2006; 82: 95-100 [PMID: 16461471].
  • 9Quattrini C, Tesfaye S. Understanding the impact of painfuldiabetic neuropathy. Diabetes Metab Res Rev 2003; 19 Suppl 1:S2-S8 [PMID: 12577252 DOI: 10.1002/dmrr.360].
  • 10Gore M, Brandenburg NA, Dukes E, Hoffman DL, Tai KS,Stacey B. Pain severity in diabetic peripheral neuropathy isassociated with patient functioning, symptom levels of anxiety anddepression, and sleep. J Pain Symptom Manage 2005; 30: 374-385[PMID: 16256902 DOI: 10.1016/j.jpainsymman.2005.04.009].

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部